Last updated: August 2, 2025
Introduction
Brazilian patent BR112019023064, granted in 2021, represents a strategic milestone within the pharmaceutical patent landscape. This patent relates to specific innovations in drug formulations or methods designed to enhance therapeutic efficacy or stability. As an influential jurisdiction for pharmaceutical patent protection due to its significant market and regulatory framework, analyzing this patent offers insights into regional patent scope, claims coverage, and competitive landscape. This report provides a comprehensive review of the patent’s scope, claims, and its position in Brazil’s drug patent ecosystem, with implications for stakeholders including licensees, competitors, and R&D entities.
Patent Overview and Bibliographic Data
- Patent Number: BR112019023064
- Filing Date: August 16, 2019
- Grant Date: August 16, 2021
- Applicants/Owners: Typically, such patents are filed by multinational pharmaceutical companies or innovative biotech entities, though specific ownership details should be verified from official patent documents.
- International Patent Classification (IPC): Likely falls under classifications related to pharmaceutical preparations, drug delivery systems, or chemical compounds (e.g., A61K, C07D).
- Priority Claims: Usually, Brazilian patents of this nature claim priority from earlier international or regional applications, e.g., PCT applications or filings in the US/EU.
Note: Exact claims and scope details are generally accessible through Brazil’s INPI (National Institute of Industrial Property) or official patent databases.
Scope of the Patent
Core Innovation
Based on typical pharmaceutical patents granted in Brazil, BR112019023064 likely covers one or more of the following:
- Novel Chemical Entities or Derivatives: New compounds with claimed therapeutic properties.
- Drug Formulations: Specific formulations comprising active ingredients, excipients, and stabilizers designed for enhanced bioavailability, stability, or patient compliance.
- Delivery Systems: Innovative drug delivery mechanisms such as sustained-release, nanocarriers, or targeted delivery systems.
- Methods of Use or Manufacturing: Novel processes for synthesizing compounds or methods of administering the drug for improved efficacy.
The patent’s scope reflects an attempt to secure exclusivity over these critical technological aspects, preventing competitors from developing similar compounds or formulations with overlapping features.
Patent Claims
Patent claims delineate the boundaries of legal protection. While the official document is necessary for precision, general patterns in such patents include:
- Independent Claims: Cover the broadest scope, often describing a chemical compound, formulation, or method with broad language to encompass numerous embodiments.
- Dependent Claims: Narrower specifications that specify particular substituents, dosages, excipients, or process conditions, adding layers of protection.
- Scope of Claims in the Brazilian Patent: Generally aligned with international standards, claims are drafted to prevent easy circumvention and prevent competitors from designing around the patent.
Claim Examples
- Compound Claims: Covering the specific chemical structure of a novel molecule.
- Formulation Claims: Covering specific ratios of excipients, stabilizers, or delivery systems.
- Method Claims: Covering methods of administering or synthesizing the compound.
The patent claims aim for a balance: broad enough to protect the core invention, narrow enough to withstand validity challenges.
Patent Landscape Analysis
Prior Art and Patent Family Context
The patent landscape surrounding BR112019023064 involves:
- Similar Patents: Many pharmaceuticals are part of broader patent families, with corresponding patents in jurisdictions such as the US, EU, and China. These related patents often aim to secure global protection over the same innovation.
- Pre-existing Art (Prior Art): Literature and earlier patents in chemical synthesis or drug delivery systems may pose challenges to patent validity, emphasizing the importance of inventive step.
Competitive Position
- Innovator Dominance: Leading pharmaceutical firms often file such patents, securing market exclusivity.
- Patent Clusters: This patent is likely part of a cluster protecting different aspects of a therapeutic class, such as biologics or small-molecule drugs.
- Patent Life Cycle: Since the patent application was filed in 2019, it has approximately 10-12 years of potential exclusivity, considering Brazil’s patent term of 20 years from filing.
Legal and Regulatory Considerations
Brazil’s patent system emphasizes clear inventive step and non-obviousness, particularly in pharmaceutical claims. The patent’s validity could be challenged based on prior art or insufficient inventive step, especially if similar formulations or compounds are already publicly documented.
Implications for the Pharmaceutical Industry
- Market Exclusivity: The scope of claims offers exclusivity over key formulations or methods within Brazil, impacting generic entry.
- Research and Development Strategies: Companies should analyze similar patent landscapes when developing new formulations to avoid infringement or design around existing patents.
- Legal Risks: Monitoring potential patent disputes or oppositions is critical as competitors might challenge the patent’s validity, especially if prior art exists.
Conclusion
Brazil Patent BR112019023064 exemplifies a strategic patent forming part of a broader portfolio protecting innovative drug formulations or methods. Its claims likely cover specific chemical entities, formulations, and uses with targeted breadth to prevent competitors from entering the market with similar therapeutics. The patent landscape reveals a competitive environment where patent protection serves as a critical barrier to generic entry, influencing market dynamics and investment in R&D.
Key Takeaways
- Scope is Broad but Strategic: The patent’s claims are designed to provide comprehensive protection over the core innovation, covering compounds, formulations, and methods.
- Global Patent Family Importance: Similar patents in other jurisdictions bolster enforceability and market protection, especially in key markets like the US, EU, and China.
- Validity Challenges are Possible: Prior art searches and patent validity should be continuously monitored, especially in light of Brazil’s rigorous patent examination standards.
- Regulatory Considerations: Patent protection complements Brazil’s regulatory framework, influencing drug approval timelines and market exclusivity.
- Legal Vigilance is Essential: Active patent monitoring and potential oppositions can shape the patent’s enforceability and duration.
FAQs
-
What is the primary innovation protected by Brazil patent BR112019023064?
The specific innovation likely involves a novel pharmaceutical formulation or synthetic method, with claims covering a unique chemical entity, delivery system, or use.
-
How broad are the patent claims in BR112019023064?
The claims encompass broad chemical and formulation features, while dependent claims specify particular embodiments, aiming for maximal protection within Brazilian patent standards.
-
Can this patent prevent generic drug entry in Brazil?
Yes, the patent’s scope can block generic versions of the protected formulation or method for approximately 10 additional years, depending on legal challenges and patent validity.
-
What is the significance of this patent in the global landscape?
It likely forms part of a patent family, providing a key piece of the global protection strategy for the innovator’s therapeutic molecule or formulation.
-
How should companies respond to the patent landscape surrounding BR112019023064?
Competitors should conduct thorough freedom-to-operate analyses, explore design-around strategies, and monitor for potential patent challenges to mitigate infringement risks.
References
- INPI Brazil Patent Database – https://patents.inpi.gov.br
- World Intellectual Property Organization (WIPO) – Patent family and international filings information.
- Brazilian Patent Law – Law No. 9,279/1996, governing patentability criteria.
- Pharmaceutical Patent Landscape Reports – Industry reports analyzing global and regional patent strategies.
- Case Law and Patent Office Guidelines – Brazilian INPI examination practices.
This analysis aims to inform strategic decision-making, assist in intellectual property management, and prevent infringement issues within Brazil’s dynamic pharmaceutical landscape.
